ANG Lifesciences India Limited (ANG.BO)
INR 45.93
(-1.12%)
INR 45.93
(-1.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.66 Billion INR | -14.12% |
| 2022 | 1.93 Billion INR | -6.65% |
| 2021 | 2.07 Billion INR | 103.06% |
| 2020 | 1.02 Billion INR | 71.49% |
| 2019 | 595.19 Million INR | 14.17% |
| 2018 | 521.3 Million INR | 15.85% |
| 2017 | 449.96 Million INR | 14.35% |
| 2016 | 393.49 Million INR | 28.08% |
| 2015 | 307.22 Million INR | 35.17% |
| 2014 | 227.28 Million INR | 1.17% |
| 2013 | 224.66 Million INR | 17.59% |
| 2012 | 191.05 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -762.77 Million INR | -145.91% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.66 Billion INR | 0.0% |
| 2023 Q2 | 1.83 Billion INR | 0.0% |
| 2023 FY | 1.66 Billion INR | -14.12% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.93 Billion INR | -6.65% |
| 2022 Q4 | 1.93 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.98 Billion INR | 0.0% |
| 2021 Q2 | 1.88 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 2.07 Billion INR | 0.0% |
| 2021 FY | 2.07 Billion INR | 103.06% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 1.02 Billion INR | 71.49% |
| 2020 Q4 | 1.02 Billion INR | 0.0% |
| 2020 Q1 | 701.91 Million INR | 17.93% |
| 2020 Q2 | 701.91 Million INR | 0.0% |
| 2019 Q1 | 530.78 Million INR | 1.82% |
| 2019 Q3 | 595.19 Million INR | 12.14% |
| 2019 Q4 | 595.19 Million INR | 0.0% |
| 2019 Q2 | 530.78 Million INR | 0.0% |
| 2019 FY | 595.19 Million INR | 14.17% |
| 2018 Q4 | 521.3 Million INR | 0.0% |
| 2018 FY | 521.3 Million INR | 15.85% |
| 2018 Q3 | 521.3 Million INR | 8.78% |
| 2018 Q2 | 479.24 Million INR | 0.0% |
| 2018 Q1 | 479.24 Million INR | 6.51% |
| 2017 Q1 | 301.48 Million INR | -23.38% |
| 2017 Q2 | 301.48 Million INR | 0.0% |
| 2017 Q3 | 449.96 Million INR | 49.25% |
| 2017 Q4 | 449.96 Million INR | 0.0% |
| 2017 FY | 449.96 Million INR | 14.35% |
| 2016 FY | 393.49 Million INR | 28.08% |
| 2016 Q3 | 393.49 Million INR | 20.05% |
| 2016 Q2 | 327.76 Million INR | 0.0% |
| 2016 Q1 | 327.76 Million INR | 0.0% |
| 2016 Q4 | 393.49 Million INR | 0.0% |
| 2015 FY | 307.22 Million INR | 35.17% |
| 2014 FY | 227.28 Million INR | 1.17% |
| 2013 FY | 224.66 Million INR | 17.59% |
| 2012 FY | 191.05 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -6365.09% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -66.767% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -7816.136% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2997.279% |
| Sunil Healthcare Limited | 902.83 Million INR | -84.043% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -77982.566% |
| MedPlus Health Services Limited | 14.27 Billion INR | 88.36% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -65.443% |
| Patidar Buildcon Limited | 25.57 Million INR | -6397.72% |
| Roopa Industries Limited | 493.08 Million INR | -236.978% |
| Smruthi Organics Limited | 485.72 Million INR | -242.089% |
| Trident Lifeline Limited | 331.26 Million INR | -401.596% |
| PANJON LTD. | 25.38 Million INR | -6446.102% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -697.155% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -927.745% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -10992.843% |
| Anuh Pharma Limited | 1.54 Billion INR | -7.573% |
| Crestchem Limited | 23.94 Million INR | -6838.644% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -12295.352% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1305.477% |
| Tyche Industries Limited | 101.64 Million INR | -1534.77% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 10.728% |
| Trimurthi Limited | 101.36 Thousand INR | -1639202.486% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -722.679% |
| Norris Medicines Limited | 278.17 Million INR | -497.325% |
| Zenlabs Ethica Limited | 301.35 Million INR | -451.377% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -470.063% |
| Parmax Pharma Limited | 117.56 Million INR | -1313.311% |
| Veerhealth Care Limited | 62.78 Million INR | -2546.698% |
| Deccan Health Care Limited | 111.33 Million INR | -1392.417% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 3.068% |
| Makers Laboratories Limited | 569.18 Million INR | -191.928% |
| Lactose (India) Limited | 536.39 Million INR | -209.77% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -99.436% |
| Zenith Healthcare Limited | 24.03 Million INR | -6813.239% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -971.549% |
| Bacil Pharma Limited | 1.12 Million INR | -147074.225% |
| PRAVEG LIMITED | 767.53 Million INR | -116.485% |
| Denis Chem Lab Limited | 289.82 Million INR | -473.316% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 3.185% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -724.238% |
| Colinz Laboratories Limited | 24.1 Million INR | -6793.163% |
| Godavari Drugs Limited | 957.86 Million INR | -73.469% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -555618.06% |
| Zenotech Laboratories Limited | 156.64 Million INR | -960.72% |
| Panchsheel Organics Limited | 340.2 Million INR | -388.415% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -240.235% |
| Vivanza Biosciences Limited | 148.63 Million INR | -1017.934% |
| Phaarmasia Limited | 211.49 Million INR | -685.644% |
| Sastasundar Ventures Limited | 1.5 Billion INR | -10.73% |
| Medi-Caps Limited | 63.01 Million INR | -2536.786% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -1311.422% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -741.856% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -46.927% |
| Mercury Laboratories Limited | 171.18 Million INR | -870.621% |
| Gennex Laboratories Limited | 535.21 Million INR | -210.456% |
| BDH Industries Limited | 312.53 Million INR | -431.651% |
| Coral Laboratories Limited | 281.83 Million INR | -489.555% |
| Concord Drugs Limited | 249.88 Million INR | -564.942% |
| Bharat Parenterals Limited | 2.65 Billion INR | 37.451% |
| Beryl Drugs Limited | 85.63 Million INR | -1840.302% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -848.579% |
| Evoq Remedies Limited | 116.23 Million INR | -1329.552% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -943.69% |
| Transchem Limited | 6.72 Million INR | -24626.146% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -18628.55% |
| Parnax Lab Limited | 1.17 Billion INR | -41.93% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -3858.823% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -57.103% |
| Cian Healthcare Limited | 1.03 Billion INR | -60.642% |
| Trinity League India Limited | 876 Thousand INR | -189580.023% |
| Syschem (India) Limited | 1.07 Billion INR | -55.185% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 18.67% |
| Natural Capsules Limited | 1.47 Billion INR | -12.482% |
| Auro Laboratories Limited | 433.09 Million INR | -283.655% |